Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
Galderma R&D
Jonathan I Silverberg; Andreas Wollenberg; Adam Reich; Diamant Thaçi; Franz J Legat; Kim A Papp; Linda Stein Gold; Jean-David Bouaziz; Andrew E Pink; José Manuel Carrascosa; Barbara Rewerska; Jacek C Szepietowski; Dorota Krasowska; Blanka Havlíčková; Monika Kalowska; Nina Magnolo; Sylvia Pauser; Navid Nami; Maxwell B Sauder; Vipul Jain; Kamila Padlewska; Soo Yeon Cheong; Patricia Fleuranceau Morel; Liliana Ulianov; Christophe Piketty; ARCADIA 1 and ARCADIA 2 Study Investigators
Biometrics, Galderma Laboratories, Dallas, TX, USA.